Cargando…
Prophylactic and therapeutic approaches for human metapneumovirus
Human metapneumovirus (HMPV) is an important pneumovirus which causes acute respiratory disease in human beings. The viral infection leads to mild to severe respiratory symptoms depending on the age and immune status of the infected individual. Several groups across the world are working on the deve...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261883/ https://www.ncbi.nlm.nih.gov/pubmed/30539045 http://dx.doi.org/10.1007/s13337-018-0498-5 |
_version_ | 1783375005424287744 |
---|---|
author | Kumar, Prashant Srivastava, Mansi |
author_facet | Kumar, Prashant Srivastava, Mansi |
author_sort | Kumar, Prashant |
collection | PubMed |
description | Human metapneumovirus (HMPV) is an important pneumovirus which causes acute respiratory disease in human beings. The viral infection leads to mild to severe respiratory symptoms depending on the age and immune status of the infected individual. Several groups across the world are working on the development of immunogens and therapy to manage HMPV infection with promising results under laboratory conditions but till date any virus specific vaccine or therapy has not been approved for clinical use. This minireview gives an overview of the prophylactic and therapeutic approaches to manage HMPV infections. |
format | Online Article Text |
id | pubmed-6261883 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer India |
record_format | MEDLINE/PubMed |
spelling | pubmed-62618832019-12-01 Prophylactic and therapeutic approaches for human metapneumovirus Kumar, Prashant Srivastava, Mansi Virusdisease Review Article Human metapneumovirus (HMPV) is an important pneumovirus which causes acute respiratory disease in human beings. The viral infection leads to mild to severe respiratory symptoms depending on the age and immune status of the infected individual. Several groups across the world are working on the development of immunogens and therapy to manage HMPV infection with promising results under laboratory conditions but till date any virus specific vaccine or therapy has not been approved for clinical use. This minireview gives an overview of the prophylactic and therapeutic approaches to manage HMPV infections. Springer India 2018-10-20 2018-12 /pmc/articles/PMC6261883/ /pubmed/30539045 http://dx.doi.org/10.1007/s13337-018-0498-5 Text en © Indian Virological Society 2018 |
spellingShingle | Review Article Kumar, Prashant Srivastava, Mansi Prophylactic and therapeutic approaches for human metapneumovirus |
title | Prophylactic and therapeutic approaches for human metapneumovirus |
title_full | Prophylactic and therapeutic approaches for human metapneumovirus |
title_fullStr | Prophylactic and therapeutic approaches for human metapneumovirus |
title_full_unstemmed | Prophylactic and therapeutic approaches for human metapneumovirus |
title_short | Prophylactic and therapeutic approaches for human metapneumovirus |
title_sort | prophylactic and therapeutic approaches for human metapneumovirus |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261883/ https://www.ncbi.nlm.nih.gov/pubmed/30539045 http://dx.doi.org/10.1007/s13337-018-0498-5 |
work_keys_str_mv | AT kumarprashant prophylacticandtherapeuticapproachesforhumanmetapneumovirus AT srivastavamansi prophylacticandtherapeuticapproachesforhumanmetapneumovirus |